Filing Details

Accession Number:
0001867096-24-000176
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-13 16:15:08
Reporting Period:
2024-08-12
Accepted Time:
2024-08-13 16:15:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1867096 Xeris Biopharma Holdings Inc. XERS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1478916 P. John Schmid C/O Xeris Biopharma Holdings, Inc.
1375 West Fulton Street, Suite 1300
Chicago IL 60607
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-08-12 4,515 $2.25 25,200 No 4 P Indirect By: The Schmid Family Trust dated August 15, 2017
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By: The Schmid Family Trust dated August 15, 2017
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 113,159 Direct
Footnotes
  1. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.